NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Xeljanz Special Investigation for Long-term Use in UC Patients

NCT03643211

CompletedN/A

Sponsor: Pfizer

Conditions: Ulcerative Colitis

Countries: Japan

Secondary data collection study: safety and effectiveness of Xeljanz in UC patients under Japanese medical practice

Eligibility overview

Sex: ALL

Age: 0 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with ulcerative colitis treated with XELJANZ
* Patients naive to XELJANZ in the treatment of ulcerative colitis

Exclusion Criteria:

\- None

Locations (1)

Tokyo, Japan